癌症
医学
生物信息学
计算生物学
生物
癌症研究
内科学
作者
Michelle Ji,Shridar Ganesan,Bing Xia,Yanying Huo
出处
期刊:Cancers
[Multidisciplinary Digital Publishing Institute]
日期:2025-04-29
卷期号:17 (9): 1493-1493
被引量:22
标识
DOI:10.3390/cancers17091493
摘要
Background: Recent research has increasingly highlighted alterations in the proto-oncogene MET, whose abnormal activation has been implicated in multiple cancers. MET encodes c-MET, a receptor tyrosine kinase critical for cellular growth, survival, and migration. Aberrant c-MET signaling, driven by mutations or gene amplification, promotes proliferation and invasion, contributing to tumorigenesis. Scope of the Review: While MET mutations are most often observed in non-small cell lung cancer (NSCLC), they also occur in other malignancies, including breast and gastric cancers. This review highlights key MET alterations, such as gene amplification, gene fusions, and exon 14 skipping deletions, and examines their prevalence across various tumor types. Major Conclusions: We discuss the clinical significance of c-MET as a therapeutic target and identify gaps in knowledge that could inform the development of alternative treatment strategies.
科研通智能强力驱动
Strongly Powered by AbleSci AI